Pendal Group Limited
- SEC CIK
- 0001541741
- Latest filing
- Jan 19, 2023
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Pendal Group Limited, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q4 2022 holdings
- Shares (Q4 2022)
- 118,417
- Value
- $85.4M
- % of portfolio
- 0.7%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 118,417 | $85.4M | 0.7% | +6,651+6.0% | Added | Holders |
| Q3 2022 | 111,766 | $77.0M | 0.7% | −47,013−29.6% | Reduced | Holders |
| Q2 2022 | 158,779 | $93.9M | 0.9% | +155,795+5,221.0% | Added | Holders |
| Q1 2022 | 2,984 | $2.08M | <0.1% | −2,262−43.1% | Reduced | Holders |
| Q4 2021 | 5,246 | $3.31M | <0.1% | +5,246 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −508−100.0% | Sold out | Holders |
| Q2 2021 | 508 | $284.0K | <0.1% | +508 | New | Holders |